new_0222_0670|CNTA|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0670|CNTA|1|Centessa Pharmaceuticals PLC PS Ratio|Centessa Pharmaceuticals PLC Price to Book Value|Centessa Pharmaceuticals PLC PEG Ratio|Centessa Pharmaceuticals PLC Price (USD)|Centessa Pharmaceuticals PLC Short Interest|Centessa Pharmaceuticals PLC Dividend Yield|Centessa Pharmaceuticals PLC Earnings Yield|Centessa Pharmaceuticals PLC Market Cap (USD)|Centessa Pharmaceuticals PLC PE Ratio|Centessa Pharmaceuticals PLC Consensus Recommendation|Centessa Pharmaceuticals PLC Price Target Num Estimates|Centessa Pharmaceuticals PLC Price Target (USD)|Centessa Pharmaceuticals PLC Revenue Estimates for Next Fiscal Year (USD)|Centessa Pharmaceuticals PLC Revenue Estimates for Current Fiscal Year (USD)|Centessa Pharmaceuticals PLC EPS Estimates for Next Fiscal Year (USD)|Centessa Pharmaceuticals PLC EPS Estimates for Current Fiscal Year (USD)|Centessa Pharmaceuticals PLC EBITDA Estimates for Current Fiscal Year (USD)|Centessa Pharmaceuticals PLC EBITDA Estimates for Next Fiscal Year (USD)|Centessa Pharmaceuticals PLC Revenue (Quarterly) (USD)|Centessa Pharmaceuticals PLC EBITDA (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net Income (Quarterly) (USD)||
new_0222_0670|CNTA|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0670|CNTA|4|quarterly|daily|quarterly|daily|monthly|daily|quarterly|daily|quarterly|monthly|monthly|monthly|quarterly|quarterly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly||
new_0222_0670|CNTA|5||1.44565217391||1.44565217391|15.5|1.44565217391||1.44565217391||23.4|29.25|29.25|146|146|29.25|29.25|29.25|39||92|92||
new_0222_0670|CNTA|6||184||184|16|184||184||10|8|8|1|1|8|8|8|6||1|1||
new_0222_0670|CNTA|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0670|CNTA|20210515||61.7625||21.75||||1901.4807|||||||||||||||
new_0222_0670|CNTA|20210615||66.959||23.58|427234|||2061.4674||1.5|2|38.5|||-3.015|-2.225|-180.354|-292.272||-41.451|-41.451|25.11|22.21
new_0222_0670|CNTA|20210715||3.4616||22.55|1062002|||2027.2315||||||||||||||22.12|20.64
new_0222_0670|CNTA|20210815||3.067||19.98|787771|||1796.19||1.6667|3|38|||-2.87|-2.42|-162.041|-259.0145||||20.1|22.05
new_0222_0670|CNTA|20210915||3.4017||22.16|854397|||1992.1707||1.6667|3|38.6667|||-2.8933|-2.2233||||-40.155|-40.155|23.06|16.7
new_0222_0670|CNTA|20211015||2.7045||16.52|1614068|||1485.1546||1.6667|||||-2.89||-155.2705|||||15.98|17.2
new_0222_0670|CNTA|20211115||2.2936||14.01|1970626|||1259.5046||1.6667|3|38.6667|||-2.8867|-2.05|-150.455|-268.914||||13.06|11.85
new_0222_0670|CNTA|20211215||2.0284||12.39|2064401|||1113.8722||1.6667|3|38.6667||||-2.0333|-150.427|||||12.75|11.26
new_0222_0670|CNTA|20220115||1.8974||11.59|2748426|||1041.9514||1.6667|3|33|||-3.1|-2.8867|-304.828|-387.98||||10.79|9.53
new_0222_0670|CNTA|20220215||1.5602||9.53||||856.7556||2|3|23|||-3.0467|-3.0333|-344.515|-402.862||||9.56|9.13